Acute myocardial ischemia in a patient with heterozygous alpha-2-plasmin inhibitor deficiency

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 7, 2009, Pages 599-600

  Brands Nijenhuis, Angelique V M ^a   Van Geel, Peter P ^b   Meijer, Karina ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Cardiology ^*

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atherosclerosis; Blood coagulation disorders; Inherited; Myocardial infarction; Plasmin inhibitor

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBOCYTIC AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE;

ADULT; ALPHA 2 ANTIPLASMIN DEFICIENCY; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CASE REPORT; COMORBIDITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HETEROZYGOTE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK FACTOR; DEFICIENCY; DISEASE MANAGEMENT; GENETICS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

ALPHA-2-ANTIPLASMIN; ATHEROSCLEROSIS; DISEASE MANAGEMENT; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 70349843637     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832d9b33     Document Type: Article

References (8)

1. Coughlin PB. Antiplasmin: the forgotten serpin? FEBS J 2005; 272:4852-4857.
2. Kordich L, Feldman L, Porterie P, Lago O. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency. Thromb Res 1985; 40:645-651.
3. Griffin GC, Mamm EF, Sokol R, Perrotta AL, Stoyanovich A, Abildgaard CF. Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage. Am J Pediatr Hematol Oncol 1993; 15:328-330.
4. Kluft C, Vellenga E, Brommer EJ, Wijngaards. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin. Blood 1982; 59:1169-1180.
5. Fay WP, Garg N, Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 2007; 27:1231-1237.
6. Matsuno H. Alpha2-antiplasmin on cardiovascular diseases. Curr Pharm Des 2006; 12841-12847.
7. Rossignol P, Luttun A, Martin-Ventura JL, Lupu F, Carmeliet P, Collen D, et al. Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost 2006; 4:664-670.
8. Matsuno H, Kozawa O, Yoshimi N, Akamatsu S, Hara A, Mori H, et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002; 100:2487-2493.